Lung health in a changing world

• 1 Macquarie University, Sydney, NSW
• 2 Concord Repatriation General Hospital, Sydney, NSW
• 3 Biomedicine Discovery Institute, Monash University, Melbourne, VIC

---

• 1. Witt C, Schubert AJ, Jehn M, et al. The effects of climate change on patients with chronic lung disease: a systematic literature review. Dtsch Arztebl Int 2015; 112: 878-883.
• 2. Collaco JM, McGready J, Green DM, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One 2011; 6: e27784.
• 3. Parameswaran U, Baird RW, Ward LM, Currie BJ. Melioidosis at Royal Darwin Hospital in the big 2009–2010 wet season: comparison with the preceding 20 years. Med J Aust 2012; 196: 345-348. <MJA full text>
• 4. Stewart JD, Smith S, Hanson J. Melioidosis in Far North Queensland is not correlated with severe weather events. Med J Aust 2017; 207: 394.
• 5. Australian Government, Office of Northern Australia. Our north, our future: white paper on developing northern Australia. Canberra: Commonwealth of Australia, 2015. http://northernaustralia.gov.au/files/files/NAWP-FullReport.pdf (accessed Sept 2017).
• 6. Lindstrom SJ, Silver JD, Sutherland MF, et al. Thunderstorm asthma outbreak of November 2016: a natural disaster requiring planning. Med J Aust 2017; 207: 235-237. <MJA full text>
• 7. Sutherland MF, Le Portelli E, Collins AL, et al. Patients with thunderstorm asthma or severe asthma in Melbourne: a comparison. Med J Aust 2017; 207: 434-435.
• 8. Ren C, Tong S. Health effects of ambient air pollution – recent research development and contemporary methodological challenges. Environ Health 2008; 7: 56.
• 9. World Health Organization. Ambient air pollution: a global assessment of exposure and burden of disease. Geneva: WHO, 2016. http://www.who.int/phe/publications/air-pollution-global-assessment/en/ (accessed Aug 2016).
• 10. Zosky GR, Hoy RF, Silverstone EJ, et al. Coal workers’ pneumoconiosis: an Australian perspective. Med J Aust 2016; 204: 414-418. <MJA full text>
• 11. Olsen NJ, Franklin PJ, Reid A, et al. Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust 2011; 195: 271-274. <MJA full text>
• 12. Hoy RF, Brims F. Occupational lung diseases in Australia. Med J Aust 2017; 207: 443-448.
• 13. Musk AW, de Klerk N, Brims FJ. Mesothelioma in Australia: a review. Med J Aust 2017; 207: 449-452.
• 14. Millard J, Moore DAJ. Multidrug resistant tuberculosis. BMJ 2015; 350: h882.
• 15. Dowling HF, Lepper MH. Effect of antibiotics (penicillin, aureomycin, and terramycin) on fatality rate and incidence of complications in pneumococcic pneumonia: comparison with other methods of therapy. Am J Med Sci 1951; 222: 396-402.
• 16. Sidjabat HE, Paterson DL. Multidrug-resistant Escherichia coli in Asia: epidemiology and management. Expert Rev Anti Infect Ther 2015; 13: 575-591.
• 17. Charu V, Zeger S, Gog J, et al. Human mobility and the spatial transmission of influenza in the United States. PLoS Comput Biol 2017; 13: e1005382.
• 18. Australian Government, Department of Foreign Affairs and Trade. Composition of Australia’s trade in services with our major trading partners: 2006 to 2016. http://dfat.gov.au/about-us/publications/Documents/australias-trade-in-services-2006-2016.pdf (accessed Aug 2017).
• 19. Australian Institute of Health and Welfare. National Drug Strategy Household Survey (NDSHS) 2016 — key findings. https://www.aihw.gov.au/reports/illicit-use-of-drugs/ndshs-2016-key-findings/contents/tobacco-smoking (accessed Aug 2017).
• 20. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr 2017; 171: 788-797.
• 21. Bonevski B, Borland R, Paul CL, et al. No smoker left behind: it’s time to tackle tobacco in Australian priority populations. Med J Aust 2017; 207: 141-142. <MJA full text>
• 22. Freeman B. Challenging how tobacco is sold in Australia. Med J Aust 2017; 207: 417-418.
• 23. MacKenzie R, LeGresley E, Daube M. Legal does not mean unaccountable: suing tobacco companies to recover health care costs. Med J Aust 2017; 207: 419-421.
• 24. O’Donnell DE, Ciavaglia CE, Neder JA. When obesity and chronic obstructive pulmonary disease collide: physiological and clinical consequences. Ann Am Thorac Soc 2014; 11: 635-644.
• 25. Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010; 363: 1991-2003.
• 26. Zhang C, Wei B, Li P, et al. Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs. PLoS One 2017; 12: e0173524.
• 27. Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 2011; 13: 499-504.